Showing results (1151-1160 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|June 2, 2021
Real-world effectiveness of pembrolizumab in advanced melanoma: analysis of a French national clinicobiological databaseEmilie Casarotto, Sheenu Chandwani, Laurent Mortier, et al.Immunotherapy|February 19, 2020
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancerCecilia Bozzetti, Anna Squadrilli, Rita Nizzoli, et al.Immunotherapy|July 7, 2021
Volume increase of spleen in melanoma patients undergoing immune checkpoint blockadeLaura Susok, Dominik Reinert, Carsten Lukas, et al.Immunotherapy|June 5, 2014
Arguing the misconceptions in allergen-specific immunotherapyErminia Ridolo, Marcello Montagni, Laura Bonzano, et al.Immunotherapy|July 21, 2020
PD-1, CTLA4, PD-L1 and PD-L2 DNA methylation in papillary thyroid carcinomaLuka de Vos, Jörn Dietrich, Sebastian Strieth, et al.Immunotherapy|March 26, 2015
Adoptively transferred Tregs accumulate in a site-specific manner and ameliorate signs of less advanced collagen-induced arthritis progress in ratsIsaura Felcenloben, Tomasz Piasecki, Julia Miller, et al.Immunotherapy|March 26, 2015
ErbB-targeted CAR T-cell immunotherapy of cancerLynsey M Whilding, John MaherImmunotherapy|March 26, 2015
Rationale for combining immunotherapy with chemotherapyAngus G DalgleishImmunotherapy|April 25, 2023
Moving beyond single-agent checkpoint inhibition in biliary tract cancers: what is the next frontier?Pedro Luiz Serrano Uson Junior, Tanios Bekaii-SaabImmunotherapy|May 4, 2023
Impact of Helicobacter pylori infection on the efficacy of immune checkpoint inhibitors for cancer treatment: a meta-analysisMaryam Noori, Farimah Fayyaz, Nima RezaeiPageof 188